Edition:
United States

Aytu BioScience Inc (AYTU.OQ)

AYTU.OQ on NASDAQ Stock Exchange Capital Market

0.34USD
4:00pm EDT
Change (% chg)

$0.00 (+1.27%)
Prev Close
$0.33
Open
$0.31
Day's High
$0.34
Day's Low
$0.31
Volume
149,551
Avg. Vol
552,173
52-wk High
$6.35
52-wk Low
$0.29

Latest Key Developments (Source: Significant Developments)

Aytu Bioscience Q3 Loss Per Share $0.24
Monday, 14 May 2018 04:05pm EDT 

May 14 (Reuters) - Aytu BioScience Inc ::AYTU BIOSCIENCE PROVIDES FISCAL THIRD QUARTER 2018 BUSINESS UPDATE.AYTU BIOSCIENCE INC - QTRLY LOSS PER SHARE $0.24.  Full Article

Aytu Bioscience Q2 Revenue $1.1 Mln, An Increase Of 32 pct
Thursday, 8 Feb 2018 04:01pm EST 

Feb 8 (Reuters) - Aytu Bioscience Inc ::AYTU BIOSCIENCE INC - TOTAL REVENUE FOR Q2 WAS ABOUT $1.1 MILLION, AN INCREASE OF 32%.AYTU BIOSCIENCE INC QTRLY LOSS PER SHARE $0.89.  Full Article

Acerus Pharmaceuticals Announces C$1.6 Million Worth Purchase Orders
Thursday, 30 Nov 2017 07:00am EST 

Nov 30 (Reuters) - Acerus Pharmaceuticals Corporation ::ACERUS PHARMACEUTICALS - ANNOUNCED C$1.6 MILLION WORTH OF NATESTO PURCHASE ORDERS FROM ITS U.S. LICENSEE AYTU BIOSCIENCE.  Full Article

Aytu Bioscience files for mixed shelf of upto $100 mln
Wednesday, 22 Nov 2017 05:30pm EST 

Nov 22 (Reuters) - Aytu Bioscience Inc :Aytu Bioscience Inc files for mixed shelf of upto $100 million - SEC Filing.  Full Article

Aytu Bioscience receives market approval from the Australian therapeutic goods administration for the Mioxsys® system
Tuesday, 7 Nov 2017 08:05am EST 

Nov 7 (Reuters) - Aytu Bioscience Inc ::Aytu Bioscience receives market approval from the Australian therapeutic goods administration for the Mioxsys® system for male infertility.Aytu Bioscience Inc - ‍expects to announce a distribution partner and launch Mioxsys for clinical use in coming quarters​.Aytu Bioscience Inc - ‍has engaged in australian market development activities and is in early discussions with distribution partners​.Aytu Bioscience - ‍Mioxsys been approved by TGA as an aid in diagnostic assessment of semen quality for patients undergoing male infertility evaluation​.  Full Article

Aytu Bioscience CFO Gregory Gould resigns
Friday, 27 Oct 2017 04:51pm EDT 

Oct 27 (Reuters) - Aytu Bioscience Inc :Aytu Bioscience Inc - ‍on October 26, 2017, Gregory A. Gould resigned as Chief Financial Officer​.Aytu Bioscience Inc - ‍Gould's resignation will become effective on November 15, 2017 -​ SEC filing.  Full Article

BRIEF-Aytu Bioscience Q3 Loss Per Share $0.24

* AYTU BIOSCIENCE PROVIDES FISCAL THIRD QUARTER 2018 BUSINESS UPDATE